Moneycontrol
HomeNewsBusinessStocksGlaxoSmithKline shares fall 2.16%; stock among top losers on Nifty Midcap 150
Trending Topics

GlaxoSmithKline shares fall 2.16%; stock among top losers on Nifty Midcap 150

The stock was witnessing negative sentiment, according to Moneycontrol analysis.

September 12, 2025 / 12:22 IST
Story continues below Advertisement
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Shares of GlaxoSmithKline were trading lower in Friday's session. The stock was among the top losers on the Nifty Midcap 150 index, declining 2.16%. At 12:00 pm, the stock was trading at Rs 2,802.00.

The annual consolidated revenue for GlaxoSmithKline increased from Rs 3,453.71 Crore in March 2024 to Rs 3,749.21 Crore in March 2025. The net profit also saw an increase, rising from Rs 589.96 Crore to Rs 927.58 Crore over the same period.

Story continues below Advertisement

The quarterly consolidated revenue for GlaxoSmithKline was Rs 805.17 Crore for the quarter-ending June 2025, compared to Rs 974.37 Crore for the quarter-ending March 2025. The net profit for the same period was Rs 205.01 Crore, down from Rs 262.87 Crore in the previous quarter.

GlaxoSmithKline Consolidated Financials (Crore)
HeadingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
RevenueRs 3,749.21Rs 3,453.71Rs 3,251.72Rs 3,278.03Rs 2,925.60
Net ProfitRs 927.58Rs 589.96Rs 607.64Rs 380.77Rs 287.27
EPSRs 54.52Rs 41.14Rs 36.08Rs 99.29Rs 31.35
BVPSRs 115.19Rs 104.93Rs 102.79Rs 157.19Rs 87.26
ROERs 47.67Rs 33.42Rs 35.41Rs 63.64Rs 24.22
Debt to EquityRs 0.00Rs 0.00Rs 0.00Rs 0.00Rs 0.00
GlaxoSmithKline Quarterly Consolidated Income Statement
Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
SalesRs 805 CroreRs 974 CroreRs 949 CroreRs 1,010 CroreRs 814 Crore
Other IncomeRs 43 CroreRs 40 CroreRs 35 CroreRs 34 CroreRs 35 Crore
Total IncomeRs 848 CroreRs 1,015 CroreRs 984 CroreRs 1,045 CroreRs 850 Crore
Total ExpenditureRs 569 CroreRs 655 CroreRs 676 CroreRs 701 CroreRs 600 Crore
EBITRs 279 CroreRs 359 CroreRs 308 CroreRs 344 CroreRs 249 Crore
InterestRs 0 CroreRs 0 CroreRs 0 CroreRs 0 CroreRs 0 Crore
TaxRs 73 CroreRs 95 CroreRs 78 CroreRs 91 CroreRs 67 Crore
Net ProfitRs 205 CroreRs 262 CroreRs 229 CroreRs 252 CroreRs 182 Crore

GlaxoSmithKline announced a final dividend of Rs 42 per share with effective date as 30 May, 2025. Also, the company had announced an interim dividend of Rs 12 per share with effective date as 07 Nov, 2024.

The stock was witnessing negative sentiment, according to Moneycontrol analysis.

Alpha Desk
first published: Sep 12, 2025 12:22 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!